Treatment of cancer with peptide analog of bombesin, GRP, litorin or neuromedin
US5217955A · kind A · utility
18Cited by
0References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 1990 |
| Grant date | Jun 8, 1993 |
| Priority date | — |
| Expiry date | May 9, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating cancer in a human patient, the method involving administering to the patient a cancer cell inhibiting amount of an analog of a naturally occurring biologically active peptide or a fragment thereof, the peptide being one of mammalian gastrin-releasing peptide, neuromedin B, neuromedin C, amphibian bombesin, or litorin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.